Hannah McEwen is the Head of Engineering Sciences for the Lung Cancer Initiative, Johnson & Johnson, where she leads the scientific and technical medical device strategy for the LCI, a cross-sector initiative meant to prevent, intercept and cure lung cancer.
Hannah has led global R&D teams within Johnson & Johnson to deliver innovative Orthopedic and Surgery solutions for sixteen years, working in the UK and USA. Prior to her current role, Hannah was Senior R&D Director, Exploratory Innovation at Ethicon. In this role, she shaped and implemented a robust portfolio grounded in clinical unmet needs for core and future platforms as well as merging and enhancing innovation strategy (product, portfolio, IP) with newly acquired technologies and capabilities. She led Oncology disease state innovation, contributing to the acquisition of Torax Medical and investment in multiple external innovation deals.
Previously, Hannah led Knee Development in DePuy Synthes, where she supported team based multi-disciplinary projects in the design, development and manufacturing of new implant/instrumentation systems, including executing the successful WW launch of the ATTUNE Knee System, the largest R&D project in the history of DePuy Synthes Joint Reconstruction.
Hannah is a champion of Diversity & Inclusion, acting as co-lead for the Cincinnati Chapter of WLI for the past three years, and actively participating in campus and community D&I activities. She is a graduate of J&J’s Accelerate Enterprise Leadership program.
Hannah holds a Bachelor of Engineering (Medical) degree from Queensland University of Technology, Australia, and a PhD in Biomedical Engineering from University of Leeds, UK.